ENERGY SUPPLY FROM CONTINUOUS VENOVENOUS HEMOFILTRATION IN CRITICALLY ILL PATIENTS

被引:0
|
作者
New, A. M. [1 ]
Nystrom, E. M. [1 ]
Frazee, E. N. [1 ]
Kashani, K. B. [1 ]
Dillon, J. J. [1 ]
Miles, J. M. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
191
引用
下载
收藏
页码:143 / 143
页数:1
相关论文
共 50 条
  • [31] Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
    Bilgrami, I.
    Roberts, J. A.
    Wallis, S. C.
    Thomas, J.
    Davis, J.
    Fowler, S.
    Goldrick, P. B.
    Lipman, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2974 - 2978
  • [32] Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients
    Petejova, Nadezda
    Martinek, Arnost
    Zahalkova, Jana
    Duricova, Jana
    Brozmannova, Hana
    Urbanek, Karel
    Grundmann, Milan
    Plasek, Jiri
    Kacirova, Ivana
    BIOMEDICAL PAPERS-OLOMOUC, 2014, 158 (01): : 65 - 72
  • [33] ACYCLOVIR TREATMENT IN THE CRITICALLY ILL THE INFLUENCE OF CONTINUOUS VENOVENOUS HEMOFILTRATION ON SERUM LEVEL ACYCLOVIR
    Paauw, R.
    Bosman, R. J.
    Franssen, E. J. F.
    van der Voort, P. H. J.
    INTENSIVE CARE MEDICINE, 2011, 37 : S265 - S265
  • [34] Fluconazole Pharmacokinetics in a Morbidly Obese, Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
    Lopez, Natasha D.
    Phillips, Kristy M.
    PHARMACOTHERAPY, 2014, 34 (09): : A162 - A168
  • [35] Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
    N Petejova
    J Duricova
    A Martinek
    J Zahalkova
    Critical Care, 17 (Suppl 2):
  • [36] Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
    Koning, Mark V.
    Roest, Asselina A.
    Vervloet, Marc G.
    Groeneveld, A. B. Johan
    Nurmohamed, Shaikh A.
    NEPHRON EXTRA, 2011, 1 (01): : 91 - 100
  • [37] High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
    R Van Ketel
    I Meynaar
    L Dawson
    S Sleeswijk Visser
    M Van Spreuwel-Verheijen
    P Tangkau
    Critical Care, 12 (Suppl 2):
  • [38] Regional Citrate Anticoagulation Reduces Polymorphonuclear Cell Degranulation in Critically Ill Patients Treated With Continuous Venovenous Hemofiltration
    Tiranathanagul, Khajohn
    Jearnsujitwimol, Onanong
    Susantitaphong, Paweena
    Kijkriengkraikul, Narin
    Leelahavanichkul, Asada
    Srisawat, Nattachai
    Praditpornsilpa, Kearkiat
    Eiam-Ong, Somchai
    THERAPEUTIC APHERESIS AND DIALYSIS, 2011, 15 (06) : 556 - 564
  • [39] CONTINUOUS VENOVENOUS HEMOFILTRATION VERSUS CONVENTIONAL TREATMENT FOR ACUTE SEVERE HYPERNATREMIA IN CRITICALLY ILL PATIENTS: A RETROSPECTIVELY STUDY
    Sun, Shiren
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [40] Regional citrate anticoagulation in continuous venovenous hemofiltration (CVVH) in critically ill patients with high risk of bleeding.
    Palsson, R
    Bazari, H
    Fang, LST
    Rubin, NT
    Niles, JL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0849 - A0849